Search results for "Medical Microbiology"

showing 10 items of 181 documents

Frequency of exposure of endangered Caspian seals to Canine distemper virus, Leptospira interrogans, and Toxoplasma gondii

2017

Canine distemper virus (CDV), Leptospira interrogans, and Toxoplasma gondii are potentially lethal pathogens associated with decline in marine mammal populations. The Caspian Sea is home for the endangered Caspian seal (Pusa caspica). In the late 1990s and early 2000s, CDV caused a series of mortality events involving at least several thousand Caspian seals. To assess current infection status in Caspian seals, we surveyed for antibodies to three pathogens with potential to cause mortality in marine mammals. During 2015-2017, we tested serum samples from 36, apparently healthy, Caspian seals, accidentally caught in fishing nets in the Caspian Sea off Northern Iran, for antibodies to CDV, L. …

SerotypeAgingVeterinary medicineSeals EarlessPhysiologyanimal diseaseslcsh:MedicineAntibodies ProtozoanMarine and Aquatic SciencesAntibodies ViralPathology and Laboratory MedicineBiochemistryToxoplasma Gondii0403 veterinary science0302 clinical medicineImmune PhysiologyMedicine and Health Scienceslcsh:ScienceDistemper Virus CanineMammalsLeptospiraProtozoanseducation.field_of_studySealsImmune System ProteinsMultidisciplinarybiologyEukaryota04 agricultural and veterinary sciencesAntibodies BacterialLeptospirosisBacterial PathogensLeptospira InterrogansMedical MicrobiologyVertebratesPathogensToxoplasmaLeptospira interrogansResearch Article040301 veterinary sciencesImmunology030231 tropical medicinePopulationMarine BiologyMicrobiologyAntibodies03 medical and health sciencesDogsLeptospiraparasitic diseasesmedicineAnimalsLeptospirosisDistemperMarine MammalseducationMicrobial PathogensPusaBacteriaCanine distemperlcsh:ROrganismsBiology and Life SciencesProteinsToxoplasma gondiibiology.organism_classificationmedicine.diseaseParasitic ProtozoansToxoplasmosis AnimalAmniotesEarth Scienceslcsh:QPLOS ONE
researchProduct

Typhoid fever as a cause of opportunistic infection: case report.

2005

Abstract Background Typhoid fever is a systemic infection caused by the bacterium Salmonella enterica subspecies enterica serotype typhi, which is acquired by ingestion of contaminated food and water. Each year the disease affects at least 16 million persons world-wide, most of whom reside in the developing countries of Southeast Asia and Africa. In Italy the disease is uncommon with a greater number of cases in Southern regions than in Northern ones. Case presentation We report on a 57-year-old Sri-Lankan male affected by typhoid fever, the onset of which was accompanied by oropharyngeal candidiasis. This clinical sign was due to a transient cell-mediated immunity depression (CD4+ cell cou…

SerotypeMalemedicine.medical_specialtyOpportunistic infectionCase ReportDiseaseOpportunistic InfectionsTyphoid feverlcsh:Infectious and parasitic diseasesMicrobiologythiphoidMedical microbiologyAnti-Infective AgentsCandidiasis OralmedicineHumanslcsh:RC109-216Typhoid FeverSri Lankabiologybusiness.industryMiddle Agedbiology.organism_classificationmedicine.diseasebacterial infections and mycosesVirologyInfectious DiseasesParasitologySalmonella entericaTropical medicinebusinessBMC infectious diseases
researchProduct

Electropherotype heterogeneity within serotypes of human rotavirus strains circulating in Italy

1987

Using solid-phase immune electron microscopy, 126 of 129 human rotavirus (HRV) strains could be serotyped directly in stools collected in Italy during the period 1981–1985. Prevalence was 70.5 per cent for serotype 1, and 13.2 per cent for each of serotypes 2 and 4. No serotype 3 strain was detected. In parallel, for 39 of 61 HRV strains tested the electropherotype of genomic RNA was successfully determined. Different electropherotypes were detected among strains of the same serotype, whereas the same electropherotype was found in HRV strains of different serotypes. Serotyping and electropherotyping of HRV strains appear to be complementary to each other, and both should be used in conjunct…

Serotypemedicine.medical_specialtyMolecular epidemiologyvirus diseasesReoviridaeGeneral MedicineBiologymedicine.disease_causebiology.organism_classificationVirologyVirusMicrobiologyMedical microbiologyVirologyRotavirusHuman rotavirusmedicineGenomic rnaArchives of Virology
researchProduct

Oral and Vaginal Epithelial Cell Lines Bind and Transfer Cell-Free Infectious HIV-1 to Permissive Cells but Are Not Productively Infected

2014

The majority of HIV-1 infections worldwide are acquired via mucosal surfaces. However, unlike the vaginal mucosa, the issue of whether the oral mucosa can act as a portal of entry for HIV-1 infection remains controversial. To address potential differences with regard to the fate of HIV-1 after exposure to oral and vaginal epithelium, we utilized two epithelial cell lines representative of buccal (TR146) and pharyngeal (FaDu) sites of the oral cavity and compared them with a cell line derived from vaginal epithelium (A431) in order to determine (i) HIV-1 receptor gene and protein expression, (ii) whether HIV-1 genome integration into epithelial cells occurs, (iii) whether productive viral in…

Sexual transmissionTranscription GeneticVirus IntegrationScienceReceptors Cell SurfaceGenome ViralBiologyMicrobiologyCXCR4EpitheliumVirusCell LineFlow cytometryViral ProteinsImmunodeficiency VirusesmedicineHumansRNA MessengerOral mucosaMicrobial PathogensMultidisciplinarymedicine.diagnostic_testQMouth MucosaRBiology and Life SciencesHIVCorrectionEpithelial CellsVirologyMolecular biologyEpitheliumBiological Tissuemedicine.anatomical_structureGene Expression RegulationTranscytosisMedical MicrobiologyCell cultureViral PathogensDNA ViralVaginaHIV-1MedicineFemaleAnatomyResearch Article
researchProduct

Genetic relatedness among isolates of Shigella sonnei carrying class 2 integrons in Tehran, Iran, 2002–2003

2007

Abstract Background Shigella spp. are major cause of diarrhoeal disease in both developing and developed countries. Shigella sonnei is the serogroup of Shigella most frequently responsible for sporadic and epidemic enteritis in developed countries. In recent years the emergence and spread of S. sonnei biotype g carrying class 2 integron have been frequently reported in many countries. Recently, S. sonnei has been reported as the prevalent serogroup of Shigella in Iran. The present study was carried out to investigate phenotypic and genetic characteristics of Shigella sonnei isolates identified in the years 2002 and 2003 in Tehran, Iran. Methods Biotyping, drug susceptibility testing, pulsed…

Shigellosismedicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaEndemic DiseasesGenotypeShigella sonneiBiologyIranmedicine.disease_causeIntegronSettore MED/42 - Igiene Generale E ApplicataEnteritisMicrobiologyIntegronslcsh:Infectious and parasitic diseasesMedical microbiologyGenotypeDrug Resistance BacterialmedicinePrevalenceHumansShigella sonneiShigellalcsh:RC109-216Shigella enteritis IranDysentery Bacillarybiochemical phenomena metabolism and nutritionmedicine.diseasebacterial infections and mycosesPhenotypeInfectious DiseasesParasitologybiology.proteinbacteriaResearch ArticleBMC Infectious Diseases
researchProduct

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluat…

2017

Background: Few data are available on the virological and clinical outcomes of advanced liver disease patients retreated after first-line DAA failure. Aim: To evaluate DAA failure incidence and the retreatment clinical impact in patients treated in the advanced liver disease stage. Methods: Data on HCV genotype, liver disease severity, and first and second line DAA regimens were prospectively collected in consecutive patients who reached the 12-week post-treatment and retreatment evaluations from January 2015 to December 2016 in 23 of the PITER network centers. Results: Among 3,830 patients with advanced fibrosis (F3) or cirrhosis, 139 (3.6%) failed to achieve SVR. Genotype 3, bilirubin lev…

SimeprevirMaleGenetics and Molecular Biology (all)HepacivirusPediatricsGastroenterologyBiochemistry0302 clinical medicineAnimal Cells80 and overBileMedicinePublic and Occupational HealthProspective Studieslcsh:ScienceAged 80 and overAdult; Aged; Aged 80 and over; Antiviral Agents; Drug Therapy Combination; Female; Hepatitis C; Humans; Incidence; Liver Diseases; Male; Middle Aged; Prospective Studies; Biochemistry Genetics and Molecular Biology (all); Agricultural and Biological Sciences (all)Liver DiseaseIncidenceLiver DiseasesChild HealthBloodCirrhosisPhysical SciencesRegression Analysis030211 gastroenterology & hepatologyDrug Therapy CombinationCellular TypesStatistics (Mathematics)Humanmedicine.medical_specialtyGastroenterology and HepatologyMicrobiologyAntiviral Agents03 medical and health sciencesDrug TherapyHumansStatistical MethodsAgedBlood CellsBiochemistry Genetics and Molecular Biology (all)Flaviviruseslcsh:ROrganismsBiology and Life Sciencesmedicine.diseaseRegimenProspective Studie030104 developmental biologychemistryAgricultural and Biological Sciences (all)lcsh:QMathematicsDevelopmental BiologyRNA viruses0301 basic medicineDAA HCV resistanceSofosbuvirPhysiologylcsh:MedicineLiver diseasechemistry.chemical_compoundMathematical and Statistical TechniquesMedicine and Health SciencesPathology and laboratory medicineMultidisciplinaryHepatitis C virusHepatitis CMedical microbiologyMiddle AgedHepatitis CBody FluidsVirusesCombinationFemaleAnatomyPathogensResearch Articlemedicine.drugPlateletsLedipasvirAdultDaclatasvirSettore MED/12 - GASTROENTEROLOGIAHCV liver diseases Cirrhosis DAA failureResearch and Analysis MethodsInternal medicineAntiviral Agentbusiness.industryViral pathogensBilirubinCell BiologyFibrosisHepatitis virusesMicrobial pathogensSurgeryLiver functionbusiness
researchProduct

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) …

2017

Background HCV GT4 accounts for up to 20% of HCV infections worldwide. Simeprevir, given for 12 weeks as part of a 24- or 48-week combination regimen with PR is approved for the treatment of chronic HCV GT4 infection. Primary study objectives were assessment of efficacy and safety of simeprevir plus PR in treatment-naïve patients with HCV GT4 treated for 12 weeks. Primary efficacy outcome was sustained virologic response 12 weeks post-treatment (SVR12). Additional objectives included investigation of potential associations of rapid virologic response and baseline factors with SVR12. Methods This multicentre, open-label, single-arm study (NCT01846832) evaluated efficacy and safety of simepre…

SimeprevirMalePsychologie appliquéeFetge - MalaltiesHepacivirusGastroenterologyPolyethylene GlycolPolyethylene Glycols0302 clinical medicinelcsh:Science61 - MedicinaLiver DiseasesSciences bio-médicales et agricolesCirrhosisInterferonLiver Fibrosis030211 gastroenterology & hepatologyDrug Therapy CombinationViral loadBiologieHumanmedicine.medical_specialtyCiències multidisciplinàriesGenotypeSaudi ArabiaAlpha interferon:Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores]Gastroenterology and HepatologyMicrobiologyAntiviral Agents03 medical and health sciencesHumansAgedMedicine and health sciencesHepaciviruFlavivirusesInterleukinslcsh:ROrganismsInterleukinmedicine.diseaseRegimen:Digestive System Diseases::Liver Diseases [DISEASES]chemistryImmunologylcsh:QMedicaments - AdministracióDevelopmental BiologyRNA viruseslcsh:Medicinemedicine.disease_cause:Other subheadings::Other subheadings::/drug therapy [Other subheadings]Geographical Locationschemistry.chemical_compoundSimeprevirHospital Universitari Vall d’Hebron030212 general & internal medicinePathology and laboratory medicineMultidisciplinaryHepatitis C virusHepatitis CRecombinant ProteinMedical microbiologyMiddle AgedViral LoadHepatitis CRecombinant Proteins:enfermedades del sistema digestivo::enfermedades hepáticas [ENFERMEDADES]EuropeResearch DesignVirusesFemalePathogensResearch ArticleAdultAsiaAdolescentClinical Research DesignHepatitis C virusResearch and Analysis MethodsYoung AdultInternal medicineRibavirinmedicineddc:610Rapid Virologic ResponseAntiviral AgentBiology and life sciencesbusiness.industryRibavirinViral pathogensInterferon-alphaFibrosisHepatitis virusesMicrobial pathogensPeople and PlacesAdverse EventsInterferonsbusinessPLoS ONE
researchProduct

One is not enough: On the effects of reference genome for the mapping and subsequent analyses of short-reads.

2020

Mapping of high-throughput sequencing (HTS) reads to a single arbitrary reference genome is a frequently used approach in microbial genomics. However, the choice of a reference may represent a source of errors that may affect subsequent analyses such as the detection of single nucleotide polymorphisms (SNPs) and phylogenetic inference. In this work, we evaluated the effect of reference choice on short-read sequence data from five clinically and epidemiologically relevant bacteria (Klebsiella pneumoniae, Legionella pneumophila, Neisseria gonorrhoeae, Pseudomonas aeruginosa and Serratia marcescens). Publicly available whole-genome assemblies encompassing the genomic diversity of these species…

Systematic errorSingle Nucleotide PolymorphismsPathology and Laboratory MedicineGenomeKlebsiella PneumoniaeDatabase and Informatics MethodsData sequencesKlebsiellaMedicine and Health SciencesBiology (General)CladePhylogenyData ManagementEcologyPhylogenetic treeBacterial GenomicsMicrobial GeneticsChromosome MappingHigh-Throughput Nucleotide SequencingPhylogenetic AnalysisGenomicsBacterial PathogensPhylogeneticsLegionella PneumophilaComputational Theory and MathematicsMedical MicrobiologyModeling and SimulationPathogensSequence AnalysisResearch ArticleComputer and Information SciencesBioinformaticsQH301-705.5LegionellaSequence alignmentSingle-nucleotide polymorphismGenomicsComputational biologyMicrobial GenomicsBiologyResearch and Analysis MethodsPolymorphism Single NucleotideMicrobiologyCellular and Molecular NeurosciencePhylogeneticsGeneticsSNPBacterial GeneticsEvolutionary SystematicsMolecular BiologyMicrobial PathogensEcology Evolution Behavior and SystematicsTaxonomyEvolutionary BiologyBacteriaOrganismsBiology and Life SciencesBacteriologySequence AlignmentGenome BacterialReference genomePLoS Computational Biology
researchProduct

Assessment of the antioxidant and antibacterial activities of different olive processing wastewaters.

2017

Olive processing wastewaters (OPW), namely olive mill wastewater (OMW) and table-olive wastewaters (TOW) were evaluated for their antibacterial activity against five Gram-positive and two Gram-negative bacteria using the standard disc diffusion and thin layer chromatography (TLC)-bioautography assays. Disc diffusion screening and bioautography of OMW were compared to the phenolic extracts of table-olive brines. Positive activity against S. aureus was demonstrated. The optimization of chromatographic separation revealed that hexane/acetone in the ratio of 4:6 was the most effective for phenolic compounds separation. A HPLC-MS analysis was performed showing that only two compounds, hydroxytyr…

Thin-Layer Chromatography0301 basic medicineDPPHStaphylococcuslcsh:MedicineWastewaterPathology and Laboratory MedicineBiochemistryAntioxidantsMass Spectrometrychemistry.chemical_compoundPlant ProductsMedicine and Health SciencesStaphylococcus Aureuslcsh:ScienceChromatography High Pressure LiquidMultidisciplinaryBioautographyAntimicrobialsChromatographic TechniquesOlivesDrugsAgriculture04 agricultural and veterinary sciencesPlants040401 food scienceThin-layer chromatographyBacterial PathogensAnti-Bacterial AgentsHexaneChemistryBioassays and Physiological AnalysisMedical MicrobiologyPhysical SciencesPathogensAntibacterial activityResearch ArticleMicrobial Sensitivity TestsResearch and Analysis MethodsMicrobiologyVegetable OilsFruitsInhibitory Concentration 5003 medical and health sciences0404 agricultural biotechnologyPhenolsPicratesMicrobial ControlOleaAcetonePhenolsMicrobial PathogensPharmacologyChromatographyBacteriaBiphenyl Compoundslcsh:RChemical CompoundsOrganismsBiology and Life SciencesAgronomyTyrosolPlanar Chromatography030104 developmental biologychemistryAntibacterialsHydroxytyrosollcsh:QChromatography Thin LayerBiochemical AnalysisCrop SciencePLoS ONE
researchProduct

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development

2017

International audience; TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC). It aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. The project builds on previous collaborations from 1998 onwards funded through the EC framework programs FP5, FP6, and FP7. It has succeeded in attracting new partners from outstanding laboratories from all over the world, now totaling 40 institutions. Next to the development of novel vaccines, TB biomarker development is also considered an important asset to facilitate rational vaccine selection and development. In addition, …

TuberculosiImmunologybacille Calmette–Guérin610 Medicine & healthReview[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesTuberculosis; Bacille Calmette-Guérin; Vaccination; Biomarker; Clinical trial; Portfolio management; Discovery[SDV.BC.IC]Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB]Immunology and AllergyBacille Calmette-Guérinbacille Calmette-Guérinbacille Calmette-Guerin2403 Immunology10179 Institute of Medical MicrobiologyBacille Calmette-Guérin; Biomarker; Clinical trial; Discovery; Portfolio management; Tuberculosis; Vaccination; Immunology and Allergy; Immunologyclinical trialvaccination[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human geneticstuberculosis2723 Immunology and Allergy570 Life sciences; biologybiomarkerportfolio managementdiscovery
researchProduct